// App-Quantinova.ai

138 : Quantitative myocardial blood flow as a prognostic marker for cardiovascular outcomes in patients with type 2 diabetes mellitus a multicentre study

Researchers

Presenter

  • Noor Sharrack

Principal Investigators

  • Kristopher Knott

  • Jian L Yeo

  • Tushar Kotecha

  • Louise Brown

  • Aldostefano Porcari

  • Gaurav S Gulsin

  • Sharmaine Thirunavukarasu

  • Amrit Chowdhary

  • Eylem Levelt

  • James Moon

  • Gerry McCann

  • Marianna Fontana

  • Peter Kellman

  • Theresa Munyombwe

  • John P Greenwood

  • Peter Swoboda

  • Sven Plein

Medical Centers

  • Leeds Institute of Cardiovascular and Metabolic Medicine, 6 Clarendon Way, Leeds, LDS LS2 9DA, United Kingdom

  • St George’s Hospital

  • University of Leicester

  • Royal Free Hospital, London, UK

  • Leeds Institute of Cardiovascular and Metabolic Medicine

  • Barts Heart Centre

  • National Institutes of Health (NIH), MD

  • University of Leeds

Locations

  • United Kingdom

  • South Africa

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

  • Genetic Disorder

  • Endocrine/metabolic Diseases (ME)

Disease

  • Type 2 diabetes mellitus

  • Congestive heart failure

  • Diabetes

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A